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Abstract
Mature microRNAs (miRNAs), derived through cleavage of pre-miRNAs by the Dicer1 enzyme, regulate protein expression in
many cell-types including cells in the pancreatic islets of Langerhans. To investigate the importance of miRNAs in mouse
insulin secreting b-cells, we have generated mice with a b-cells specific disruption of the Dicer1 gene using the Cre-lox
system controlled by the rat insulin promoter (RIP). In contrast to their normoglycaemic control littermates (RIP-Cre+/2
Dicer1D/wt), RIP-Cre+/2 Dicer1flox/flox mice (RIP-Cre Dicer1D/D) developed progressive hyperglycaemia and full-blown diabetes
mellitus in adulthood that recapitulated the natural history of the spontaneous disease in mice. Reduced insulin gene
expression and concomitant reduced insulin secretion preceded the hyperglycaemic state and diabetes development.
Immunohistochemical, flow cytometric and ultrastructural analyses revealed altered islet morphology, marked decreased b-
cell mass, reduced numbers of granules within the b-cells and reduced granule docking in adult RIP-Cre Dicer1D/D mice. b-
cell specific Dicer1 deletion did not appear to disrupt fetal and neonatal b-cell development as 2-week old RIP-Cre Dicer1D/D
mice showed ultrastructurally normal b-cells and intact insulin secretion. In conclusion, we have demonstrated that a b-cell
specific disruption of the miRNAs network, although allowing for apparently normal b-cell development, leads to
progressive impairment of insulin secretion, glucose homeostasis and diabetes development.
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Introduction
The insulin-secreting function of pancreatic b-cells is one of the
most critical aspects in the development of diabetes [1] and insulin
release from pancreatic b-cells plays an essential role in blood
glucose homeostasis [2]. Insulin is synthesized through transcrip-
tion and translation of the insulin gene into preproinsulin and
cleavage of the signal peptide and the C-peptide during the
maturation process [3]. Both transcription and translation of
insulin are glucose-dependent processes. Insulin gene expression is
increased through glucose-dependent activation of specific tran-
scription factors [4] and posttranscriptional regulation of insulin
involves glucose-dependent insulin mRNA stabilization and
translation [5]. Mature insulin can remain within the insulin
granules for several days [6] before it is transported out to the
plasma membrane. A large proportion of the granules reside in a
reserve pool within the b-cell whereas ,1% of the granules are
docked and primed at the plasma membrane [7]. We and others
have hypothesized that the release of primed granules correlates
with the 1st phase insulin secretion while release of granules within
the larger reserve pool constitutes the release during the 2nd phase
insulin secretion [8,9].
MicroRNAs are a class of 19–25 nucleotide (nt)-long noncoding
RNA molecules that are involved in regulation of gene expression
[10]. Mature miRNAs are processed from double-stranded hairpin
precursors by Drosha and Dicer enzymes [11]. Only one Dicer
enzyme is present in mammals and is responsible for the final step
in miRNA processing [12]. Disruption of the catalytic process
mediated by Dicer results in lack of mature miRNAs, leading to
altered target gene expression [11]. Germline deletion of Dicer1 is
embryonically lethal in mice [13,14] and results in altered
embryonic stem cell differentiation [15].
Several miRNAs regulating different parts of the insulin-
secreting process have been identified. The b-cell enriched
miRNA miR-375 has been demonstrated to influence insulin
mRNA levels [16] as well as the exocytotic process [17].
Moreover, the level of miRNA-375, together with miRNA-127-
3p and miR-184 is positively correlated to insulin mRNA levels in
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islets from human donors and the association between these
miRNAs and b-cell function was deranged in islets from glucose
intolerant donors [18]. MiR-375 has also been implicated in b-cell
expansion and proliferation [19]. Recently, several other miRNAs
including miR-24 and miR-182 was implicated to be important for
insulin biosynthesis [20]. Other miRNAs directly regulating
insulin secretion affecting the expression of proteins involved in
the exocytotic process include miR-124a and miR-96 [21].
Indeed, it was recently shown that the predicted targets of a
number of miRNAs overexpressed in the pancreatic islets of the
type 2 diabetes model, Goto-Kakizaki rat, were shown to be
enriched for genes with central roles in exocytosis, including
Syntaxin-binding protein 1 (Stxbp1) shown experimentally to be a
target of rno-miR-335 [22]. In addition, miRNAs have been
suggested to contribute to fatty acid-induced b-cell dysfunction
[23].
b-cell specific Dicer1 deletion controlled by the Pdx1 promoter
results in aberrant pancreas development (specifically in the
insulin-secreting b-cells) and neonatal death [24]. Inactivation of
Dicer1 in adult life leads to development of diabetes due to reduced
insulin expression [20]. However, the effect of progressive loss of
Dicer 1 during life has not yet been determined. We have studied
the role of miRNAs in b-cell function and in the development of
diabetes in vivo by specifically deleting Dicer1 in pancreatic b-cells
under the RIP-promoter. Our results show that disruption of
miRNA processing in mouse pancreatic b-cells, while compatible
with b-cell development, leads to defective insulin-secreting
function and progressive overt diabetes mellitus.
Results
b-cell specific deletion of Dicer1 gene results in diabetes
development
To investigate the effect of Dicer1 deficiency on diabetes
development, we generated mice with a b-cell specific Dicer1
deletion from mid gestation (E9–11.5) using the Cre-lox
system (RIP-Cre Dicer1D/D) by crossing RIP-Cre transgenic with
Dicerflox/flox mice (Fig. 1A and B). The possibility of RIP-Cre
mediated Dicer1 deletion in brain [25] and the possible effects in
feeding behaviour and body weight was excluded by measuring
Dicer1 expression and daily measurement of body weight (Fig.
S1A–B). Feeding behavior, measured by controlling food con-
sumption, also remained unchanged between the two mouse
strains (Fig. S1C). The incidence of spontaneous diabetes was
determined in RIP-Cre Dicer1D/D mice and control littermates
(RIP-Cre Dicer1wt/D) from 2 weeks of age. Mice were considered
diabetic when blood glucose levels were $13.5 mmol/l on two
consecutive measurements. The onset of diabetes was dated to the
first of these two measurements. As shown in Fig. 1C, by 12 weeks
of age, 80% of Dicer1 deficient mice (n = 70) developed diabetes
and, by 25 weeks of age, 100% of mice were diabetic. Male mice
(n = 33) developed diabetes faster compared to females (n = 37;
p = 0.0005). Fig. 1D shows the measured plasma glucose levels in
4, 7 and 13 weeks old mice. Control littermate mice (n = 70)
always remained normoglycaemic.
In vivo impairment of glucose homeostasis in RIP-Cre
Dicer1 D/D mice
To investigate the efficiency of RIP-Cre Dicer1D/D b-cells to
maintain in vivo glucose homeostasis after glucose challenge, we
performed the intraperitoneal glucose tolerance test (ipGTT). No
differences in glucose tolerance between RIP-Cre Dicer1D/D and
control mice (Fig. 2A) were observed in 4–5 weeks old mice. By
contrast, at 13 weeks of age, RIP-Cre Dicer1D/D mice showed
extremely impaired glucose tolerance compared to control mice
(P,0.0001, Fig. 2A).
Impaired insulin secretion precedes hyperglycaemia in
RIP-Cre Dicer1D/D mice
To investigate the effects of the b-cell-specific Dicer1 deletion on
insulin secretion in vitro, we performed batch-incubations of
pancreatic islets. Islets were incubated at basal (1 mM) or
stimulating (20 mM) glucose concentration for 1 hour. Insulin
secretion in response to basal glucose concentration was normal in
young (2 and 5 weeks old) RIP-Cre Dicer1D/D mice, but
significantly reduced in 8 weeks old RIP-Cre Dicer1D/D mice
(P,0.0001, Fig. 2C). Insulin secretion in response to 20 mM
glucose was normal in 2 weeks old RIP-Cre Dicer1D/D mice, but
reduced by over 70% in 5 and 8 weeks old RIP-Cre Dicer1D/D
mice (P,0.0001, Fig. 2B and C). However, upon normalization
for insulin content insulin secretion levels in 8 weeks old mice
actually increased compared to those of controls (P,0.05, Fig. 2C).
These results indicate a defect in either insulin production, b-cell
survival or both in the RIP-Cre Dicer1D/D mice.
Dicer1 disruption in b-cells leads to morphological
changes in pancreatic islets
The histological phenotype of the pancreatic islets was
examined using H-E staining. The analysis performed on RIP-
Cre Dicer1D/D and control pancreas at 5, 8, 11 and 25 weeks of age
(Fig. 3) showed that islet morphology was clearly altered already at
5 weeks of age in RIP-Cre Dicer1D/D mice. In 25 weeks old RIP-
Cre Dicer1D/D mice the number of islets was dramatically
decreased and in general smaller compared to littermate controls.
Dicer1 disruption in b-cells leads to progressive decrease
of insulin producing cells and total b-cell mass
To visualize insulin-producing cells in situ, we performed
immunohistochemical analysis using confocal microscopy (Fig. 4).
At 5 weeks of age, the insulin to glucagon ratio (R) was not
significantly different between RIP-Cre Dicer1D/D (R= 3.360.7,
n = 6) and control littermate mice (R= 4.961.1, n= 5). In 8 to 11
weeks old mice we observed a clear reduction of b-cells in RIP-Cre
Dicer1D/D mice compared to control littermates with a relative
increase in the number of a-cells, and the ratio was 0.860.2
(n = 12) in the RIP-Cre Dicer1D/D mice islets and 3.660.6 in
control littermates (n = 12; p,0.001 control littermates vs RIP-Cre
Dicer1D/D).
Both the morphological changes and the observed decrease in
the b-cell to a-cell ratio in RIP-Cre Dicer1D/D islets could be
related to a reduced number of b-cells. To more accurately
quantify the frequency of pancreatic b- and a-cells, we performed
flow cytometric analysis of dispersed islets on 8 to 11 weeks old
RIP-Cre Dicer1D/Dmice and age-matched control littermates using
antibodies specific for insulin and glucagon. As shown in Fig. 5, we
confirmed a significant reduction of b-cells (from 6861% insulin
positive cells in control littermates to 4263% in RIP-Cre Dicer1D/D
mice; P,0.001, n= 3) with a relative increase of a-cells (from
2062% glucagon positive cells in control littermates to 3865% in
RIP-Cre Dicer1D/D mice; P,0.05, n= 3).
Based on these results, we next performed Optical Projection
Tomography (OPT) [26] to study the total b-cell mass in whole-
mounted pancreas 3-dimensionally. As shown in Fig. 6, there was
no significant difference in total number of insulin-producing cells
between RIP-Cre Dicer1D/D and control littermates at 5 weeks of
age. However, we could undoubtedly demonstrate a significant
reduction of total insulin-producing cells in RIP-Cre Dicer1D/D
Dicer1 Deletion in the Insulin-Secreting Beta-Cell
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compared to littermate control mice in 8 and 12 week old mice.
Quantification of the number of islets per pancreas in 8–12 week
old mice revealed a significant decrease from 23006451 islets/
pancreas (N= 6 mice) in control mice to 14856378 islets/
pancreas (N= 6 mice; p= 0.0035 vs control mice) in RIP-Cre
Dicer1D/D. Likewise, b-cell mass measured as b-cell volume per
whole pancreas volume [26,27] was reduced in 8 and 12 week old
RIP-Cre Dicer1D/D mice by $50% compared with their control
littermates of the same age (Fig. 6B).
Ultrastructural analysis reveals b-cell loss and reduction
of b-cell secretory granules
To better characterize the consequences of Dicer1 disruption at
single cell level, we performed transmission electron microscopy
(TEM). In 11 weeks old RIP-Cre Dicer1D/D mice, the electron
micrographs revealed an obvious reduction of the number of b-
cells within the islets compared to the control islets. The electron
micrographs indicated that the few remaining b-cells in RIP-Cre
Dicer1D/D had less insulin granules than their control littermates
(Fig. 7A). This was confirmed by ultrastructural analysis (Fig. 7B)
which revealed ,50% less granules in the RIP-Cre Dicer1D/D
compared to the controls when measured as volume-density
(Nv; Fig. 7B, left). This reduction was specific for the b-cells and
could not be observed in non-b-cells (data not shown). The
number of docked granules expressed as the surface density (Ns)
was also severely reduced in b-cells from 11 week old RIP-Cre
Dicer1D/D mice compared to control littermates (Fig. 7B, right). At
2 weeks of age this phenotypic feature had not appeared (Fig S2)
and the b-cells in RIP-Cre Dicer1D/D mice had a similar granular
volume density Nv and surface density Ns as control littermates
(Fig. 7C).
Dicer1 knockdown dramatically reduce insulin gene
expression in isolated b-cells
We next tested whether the level of Dicer1 deletion affect insulin
expression in sorted b-cells. Purified islets from 6 to 8 weeks old
Figure 1. RIP-Cre Dicer1D/D mice develop diabetes during the first 25 weeks of age. A. PCR analysis of tail genomic DNA showing the
genotypes of the mice used in the experiments, lane 1 RIP-Cre Dicer1D/D and lane 2 their control littermates RIP-Cre Dicer1D/wt B. PCR analysis of
genomic DNA from sorted b-cells demonstrating deletion of both alleles of Dicer1 gene in RIP-Cre Dicer1D/D and deletion of only one allele in control
littermates RIP-Cre Dicer1D/wt mice. Numbers below lanes represent the two PCR reactions (one for each allele) for each mouse strain. C. Cumulative
diabetes incidence in RIP-Cre Dicer1D/D mice. Glucose was measured every week from the age of 3 weeks using a glucometer. Control littermates
never develop diabetes or hyperglycaemia and are therefore not shown in the figure. D. Plasma blood glucose levels (mmol/l) measured in 4, 7 and
13 weeks old RIP-Cre Dicer1D/D mice and littermate controls as indicated. The number of animals within the different groups is indicated below. Data
are presented as mean6sd. ***P,0.001.
doi:10.1371/journal.pone.0029166.g001
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non-diabetic RIP-Cre Dicer1D/D (n = 7) and control littermates
(n = 7) were pooled and dissociated before being stained with
Newport Green-Ac and sorted by flow cytometry as described in
material and methods. The purity after sorting was .95% as
determined by insulin staining and immunofluorescence micros-
copy (data not shown). In line with the data showed above, we
could demonstrate by qPCR a 90% decrease of insulin gene
expression in RIP-Cre Dicer1D/D compared to littermate control
mice (Fig. 8 A). To verify that the knock-down of dicer effects
miRNA expression we measured the expression of the b-cell
specific miRNA, mir-375, and found that it was reduced by 70%
in the RIP-Cre Dicer1D/D compared to littermate control mice
(Fig. 8 B). This was accompanied by an accumulation of pri-
miRNA-375 in the RIP-Cre Dicer1D/D b-cells (Fig. 8B).
To investigate the effect of Dicer1 knockdown on the global
miRNA level, we hybridized total RNA from sorted b-cells of
wildtype, Dicer1flox/flox and RIP-Cre Dicer1D/D into locked nucleic
acid (LNA)-based arrays. Owing to the limited starting material,
we could only perform the experiments once for each sample and
we generally observed low signal intensities from the arrays. Of the
60 quantifiable miRNA signals, 26 miRNAs were not detectable in
RIP-Cre Dicer1D/D (Fig. S3). These include the islet-specific miR-
375 and another abundant islet miRNA, miR-7a [28]. Surpris-
ingly, 14 miRNAs were similarly expressed in the knockout
animals as in the controls while 20 miRNAs were found to be
exclusively expressed in the former (Fig. S3). Our array data
indicate the existence of both Dicer1-dependent and -independent
maturation pathway of miRNAs in line with previous studies
[29,30]. However, our array data cannot conclusively support the
extent of a Dicer1-independent pathway without further valida-
tion.
No evidence for altered b-cell proliferation or apoptosis
in RIP-Cre Dicer1D/D mice
To determine whether the observed phenotype of RIP-Cre
Dicer1D/D was due to increased b-cell apoptosis that could be
preceded or accompanied by an altered proliferative potential, we
performed in situ TUNEL assay (Fig. 9A) and we stained
pancreatic section with Ki67 specific antibodies (Fig. 9B). No
detectable increased b-cell apoptosis could be observed in any of
the strains at any time point. In addition, Ki67 staining did not
Figure 2. Impaired in vivo glucose tolerance and in vitro insulin
secretion in RIP-Cre Dicer1D/Dmice. A. In vivo glucose tolerance test
was performed on 6 control littermates and 5 RIP-Cre Dicer1D/D females
at 4–5 weeks of age (left) and 6 control littermates and 6 RIP-Cre
Dicer1D/D females at 13 weeks of age (right). Note that the glucose
levels of the 13 weeks old RIP-Cre Dicer1D/D mice reached levels not
measurable by the glucometer. Data are mean6SEM. B. Insulin
secretion from isolated pancreatic islets was measured after 1 h
incubation in 1 mM glucose (1 G) or 20 mM glucose (20 G) in 2 and
5–6 weeks old littermate control (white bar) or RIP-Cre Dicer1D/D mice
(black bar). C. (Left) As in B, but insulin secretion was measured in 7–8
weeks old mice. (Right) Insulin release normalized to insulin content.
Data are mean6SEM of 15–21 experiments in 3–5 animals. *P,0.05;
***P,0.001.
doi:10.1371/journal.pone.0029166.g002
Figure 3. Altered islet morphology in RIP-Cre Dicer1D/D mice.
H-E stainings of 5, 8, 11 and 25 weeks old littermate controls (left) or
RIP-Cre Dicer1D/D (right) mice. Representative islets of more than 5 mice
per group and age are shown. All images are 206magnification.
doi:10.1371/journal.pone.0029166.g003
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differ in islets from RIP-Cre Dicer1D/D and control littermates
(Fig. 9B).
Discussion
In this work, we demonstrate for the first time that targeted
disruption of the Dicer1 gene specifically in b-cells leads to
progressive reduction in insulin secretion, glucose tolerance and
development of diabetes. Strikingly, 100% of RIP-Cre Dicer1D/D
mice developed diabetes by 25 weeks of age indicating the
importance of the miRNAs network for the proper function of
insulin-producing cells and, in turn, for glucose metabolism. Both
in vitro and in vivo studies demonstrate a decreased response to
glucose stimulated insulin secretion in the RIP-Cre Dicer1D/D mice
from 5 weeks of age. Prior to that, b-cell mass and function were
not altered, suggesting that in our model disruption of Dicer1-
dependent miRNA processing apparently does not affect the early
stages of b-cell development. Indeed, insulin secretion in young
mice, as well as the number of secretory granules, did not differ
between RIP-Cre Dicer1D/D and littermates control mice.
Figure 4. Altered cellular morphology in RIP-Cre Dicer1D/D islets with increasing age. Confocal microscopy analysis of insulin and glucagon
staining was performed on islets from 5, 8 and 11 weeks old control littermates (upper panels) and RIP-Cre Dicer1D/D (lower panels) mice. Insulin and
glucagon staining can be observed as indicated. Notice the deformation of the RIP-Cre Dicer1D/D islet and the increased number of a-cells relative to
the reduced number of b-cells. Scale bar 20 mm.
doi:10.1371/journal.pone.0029166.g004
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While, our results partially affirm those observed by Morita
et al. [31], who reports normal fetal and neonatal pancreatic
development in Dicer1-hypomorphic mice that progress to
morphological islet abnormalities only at 4 weeks of age. Our
reported results contradict Lynn et al. [24] who observed no gross
phenotype in mice driving Dicer1 deletion using the RIP
promoter. One explanation for the discrepancy with our study
could be the different genetic background of the mouse strains
[32] or the extent of Dicer deletion. However, neither Dicer1
expression nor functional studies were performed in their
mice with RIP-driven Dicer1 deletion [24]. Pdx1-driven Dicer1
deletion in b-cells had instead a profound effect in b-cell
development [24]. The difference with our model is likely to be
due to earlier expression of Pdx1 [33] as compared with the insulin
genes [32,34], therefore earlier ablation of Dicer1 may result in a
more profound defect in b-cells reprogramming and differenti-
ation.
What is the mechanism underlying b-cell mass reduction in the
absence of the Dicer1 enzyme? Surprisingly, we could not observe
any increase of b-cell apoptosis (measured by TUNEL in situ) or an
altered b-cell proliferation based on Ki67 staining in RIP-Cre
Dicer1D/D at any time point studied. However, we cannot exclude
the possibility that b-cells undergo progressive apoptosis in a non-
synchronized way posing a technical challenge in measuring
cumulative cell death in situ at each specific time point.
Alternatively, cell death could have occurred without the classical
DNA single strands breaks measured by the TUNEL technique.
Therefore, more studies are necessary to clarify this issue.
Interestingly, we observed not only reduction in the b-cell mass
but a concomitant dramatic loss in insulin expression (Fig. 8) in the
RIP-Cre Dicer1D/D mice with a reduced number of granules within
b-cells (Fig. 7). This observation confirms the results recently
published data where Dicer1 was depleted in b-cells in adulthood
[20]. That the regulation of insulin expression is controlled by
Figure 5. Decreased insulin-producing cells in RIP-Cre Dicer1D/D islets. Islet cells suspension from 50 islets from 8 weeks old littermates and
RIP-Cre Dicer1D/D mice were stained for insulin and glucagon and analyzed by flow cytometry. Side scatter (SSC) and forward scatter (FSC) analysis of
islet cells and the respective gate used to identify live cells. Littermate control islet cells contained significantly more insulin-positive cells (P,0.001)
and less glucagon-positive cells (P,0.05) than the RIP-Cre Dicer1D/D islet cells. Representative of 3 independent experiments.
doi:10.1371/journal.pone.0029166.g005
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miRNAs demonstrate the importance of these molecules in the
control of insulin secretion. The reduced number of granules in
the b-cell (Fig. 7B) might in part be due to the reduced insulin
expression. However, the fact that no accumulation of empty
granules was observed indicates that miRNAs also are necessary
for the processing of insulin granules. The observed number of
docked granules can be a cause of the reduced number of total
granules. However, it cannot totally be excluded that depletion of
Dicer1 has a direct effect on the docking of granules due to that
many miRNAs have been proven to be important for insulin
exocytosis [35]. Indeed, the reduction in the number of docked
granules (,65%) in the RIP-Cre Dicer1D/D compared to control
mice exceeds the reduction in the total number of granules
(,50%) indicating the importance of mature miRNAs in the
regulation of the exocytotic process. Against this hypothesis is the
observation that reduced glucose-stimulated insulin secretion in
the RIP-Cre Dicer1D/D mice could entirely be explained by
reduced islet insulin content (Fig. 2C) and glucose stimulated
secretion as measured per insulin content was even significantly
increased This would suggest that under the physiological
condition of reduced insulin content, the RIP-Cre Dicer1D/D mice
try to compensate by increasing processes involved in secretion. In
such scenario, the reduced number of docked granules in the RIP-
Cre Dicer1D/D mice is more likely associated with increased fusion
of insulin granules (with less content in each granule) and failure of
replenishment of docked granules.
In comparison with earlier published work where Dicer1 deletion
was driven by the Pdx-promotor [24] or in adulthood under the
RIP-promotor [20] our data (where Dicer1 is driven by the RIP-
promotor earlier in life) demonstrate a broader phenotype. We
observe not only reduction of insulin gene expression and
concomitant reduced number of granules in the b-cells, but also
altered islet morphology and reduced b-cells mass. This suggests
that miRNAs control several important steps including insulin
Figure 6. Decreased total b-cell mass in RIP-Cre Dicer1D/D visualised by optical projection tomography. A. Optical tomographic sections
based on insulin-labeling of adult pancreas of 5, 8 and 12 weeks old RIP-Cre Dicer1 and control littermate mice. A clear decrease of total b-cells can be
observed in pancreas from 8 and 12 weeks old hyperglycemic in RIP-Cre Dicer1D/D mice. Notice that the image shown is a 2D image and that the OPT
technique generate a 3D reconstruction of the whole pancreas. B. Quantification of b-cell volume per pancreas volume from 5, 8 and 12 week old RIP-
Cre Dicer1 and control littermate mice. The number of animals used in the analysis of the different groups is given below the columns. Data are
presented as mean6SEM for the 8 and 12 week old mice. *P,0.05.
doi:10.1371/journal.pone.0029166.g006
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biosynthesis and b-cell survival. Further, Dicer1-dependent miR-
NAs are most likely controlling the islet architecture early in life
although that the observed effects on b-cell survival are visible first
around week 8 (See e.g. Fig. 4). Once Dicer1 is deleted in
adulthood islet architecture stays intact [20]. Although we were
not able to demonstrate an increase in the frequency of apoptotic
cells in the islets of RIP-Cre Dicer1D/Dmice, we cannot rule out the
possibility that b-cell loss is due to increased cell death. Our model
Figure 7. Ultrastructural changes in RIP-Cre Dicer1D/D b-cells. A. Electron micrograph of b-cells from 11 weeks old control (top) and RIP-Cre
Dicer1D/D (bottom) mice. In the left images (low magnification) the plasma membrane surrounding the analyzed b-cell is marked by a black line. The
area within the dotted rectangle is shown in the higher magnification images to the right. Docked granules are marked with black arrows in the
images to the right. Scale bars 2 mm (left images) and 0.5 mm (right images). b: b-cell; a: a-cell; d: d-cell; N: nucleus; g: granule; m:mitochondria. B.
Histograms of the total amount of granules (left) and the number of docked granules (right) within b-cells measured as volume density NV (granules/
mm3) and surface density Ns (granules/mm2), respectively. Analysis was performed on b-cells within islets from 11 weeks old control littermates (white
bar) and RIP-Cre Dicer1D/D mice (black bar). Data is expressed as mean6SEM of 23 cells in each group. ***P,0.001. The embedded islets where from
N = 4 mice. C. As in B, but analysis was performed on b-cells within islets from 2 week old control littermates (white bar) and RIP-Cre Dicer1D/D mice
(black bar). Data are from N = 2 mice each for control and RIP-Cre Dicer1D/D mice, and the mean from each of the individual mice are presented in the
graph.
doi:10.1371/journal.pone.0029166.g007
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Figure 8. Insulin, miR-375 and pri-miR-375 expression in sorted b-cells. Pancreatic islets were isolated from 7 RIP-Cre Dicer1D/D and 7
littermate control mice. b-cells were sorted using flow cytometry to .98% purity. Total RNA was extracted and used for qPCR and array hybridization.
A. Insulin mRNA expression level is reduced in RIP-Cre Dicer1D/D, B. Mature miR-375 is significantly reduced while the pri-miR-375 species accumulates
in the knockout. ***P,0.001.
doi:10.1371/journal.pone.0029166.g008
Figure 9. No evidence of increased b-cell apoptosis and altered proliferation in RIP-Cre Dicer1D/Dmice. A. b-cell apoptosis was estimated
using in situ TUNEL assay from 8–12 weeks old RIP-Cre Dicer1D/D and littermate control mice (right). No significant apoptosis could be detected in any
islets observed. Nuclease-treated pancreas section from age matched littermate control mice was used as positive control for TUNEL staining and is
depicted on the left. These are representative of several sections of individual pancreases. B. b-cell proliferation was detected in situ based on Ki67
expression and analysed by confocal microscopy in 11 weeks old mice. Upper panels depict insulin and Ki67 staining in control littermates whereas
the lower panels represent RIP-Cre Dicer1D/D pancreas. Although RIP-Cre Dicer1D/D islets have a clear decrease of insulin-producing cells compared to
control littermates, no sign of increased proliferating Ki67 positive cells is observed.
doi:10.1371/journal.pone.0029166.g009
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is indeed characterized by a progressive loss of b-cell mass, which
in time results in full blown diabetes. It is well known that
apoptotic cells are very rapidly eliminated by scavenger cells and it
is therefore likely that non synchronized apoptosis accompanied
by a rapid phagocytosis and elimination of apoptotic cells have
hampered the possibility of detecting the increase in beta cell death
that should be expected based on the phenotype of these mice.
Finally, our results highlight the role of miRNAs in diabetes
development. It is conceivable that the fine-tuning regulation of
gene expression mediated by miRNAs might have important
implication in diabetes pathogenesis also in humans [36]. In
support, we have recently published data indicating a disturbed
miRNA network in islets from human glucose intolerant donors
[18] and in the GK-rat [22]. Our mouse model suggests that
several miRNAs are involved in the development of diabetes.
Overexpression of the b-cell specific miRNA, miR-375, in
pancreatic islets reduce insulin secretion [17] and reduced b-cell
mass was detected in the miR-375 knock-out mouse as well as
hyperglycaemia [19]. Since our model is characterized by altered
miRNAs processing, including miR-375, it is likely that the
reduced expression of miR-375 in RIP-Cre Dicer1D/Dmice (Fig. 8B)
contributes to diabetes development although it appears clear that
other miRNAs have to be involved in the pathophysiology of these
mice. It remains unclear whether miR-375 knock-out mice
develop overt diabetes. In contrast, 100% of the RIP-Cre
Dicer1D/D mice developed diabetes. Thus, a number of miRNAs,
including miR-375, contribute to efficient b-cell function and
protection from diabetes. Defining the miRNA network used by b-
cells to maintain glucose homeostasis will be, in the future, very
useful to design new therapeutic strategies to prevent and
eventually reverse diabetes development.
Materials and Methods
Ethical statement
All experiments were performed in compliance with relevant
Swedish and institutional laws and guidelines and were approved
by the local ethics committee in Malmo¨ (Malmo¨-Lund animal
research ethics committee; M133-10 and M78-08).
Animals
Beta-cell specific Dicer1 deficient mice (RIP-Cre Dicer1D/D) were
generated by crossing RIP-Cre+/2 mice [37] with Dicer1flox/flox
mice, previously described [38], to obtain RIP-Cre+/2 Dicer1D/wt
which were then crossed with Dicer1flox/flox mice. All mice used in
the experiments carried the Cre transgene in heterozigosity and
RIP-Cre+/2 Dicer1D/wt littermates were used as control mice
(control). All mice were maintained on a 12-h light/dark cycle and
fed ad libitum with standard chow and tap water at Malmo¨
University Hospital animal facility.
PCR
Dicer1flox/flox genotype was determined using the following
PCR primers (59-39): AGTGTAGCCTTAGCCATTTGC and
CTGGTGGCTTGAGGACAAGAC, the wildtype (wt) allele
giving a 259 bp and the floxed allele a 309 bp PCR product.
The Cre allele was identified by a 675 bp large PCR product
amplified using the TGCCACGACCAAGTGACAGC and
CCAGGTTACGGATATAGTTCATG primers. Deletion of the
Dicer1 exon 20–21 fragment was detected using the following PCR
primers (59-39): AGTAATGTGAGCAATAGTCCCAG and
CTGGTGGCTTGAGGACAAGAC, giving a product in both
littermate controls and RIP-Cre Dicer1D/D mice of 309 bp.
Complete deletion of Dicer1 exon 20–21 results in the absence of
the 259 bp and the floxed allele a 309 bp PCR product bands in
RIP-Cre Dicer1D/D mice.
Diabetes incidence
Mice were screened for blood glucose levels weekly starting
from 3 weeks of age and were considered diabetic when glucose
levels were $13.5 mmol/l on two consecutive measurements. The
onset of diabetes was dated from the first of these sequential
measurements. Tests were done at the same time daily to avoid
variations due to feeding.
In vivo glucose tolerance test
Control mice (n = 6) and RIP-Cre Dicer1D/D mice were
subjected to intraperitoneal glucose tolerance test (ipGTT) at 4–5
weeks of age and at 13 weeks of age. Mice were anaesthetised by
i.p. injections of Hypnorm (0.315 mg/ml Fetanyl, 10 mg/ml
Fluanisone, VetaPharma) and Dormicum (5 mg/ml, Roche AB,
Stockholm) diluted four times in sterile water; 50 ml of the
Hypnorm/Dormicum mix was first injected 15 minutes before
experiment subcutaneously and then repeated every 20 minutes
i.p. The body warmth was maintained by red lamp. Mice were
injected intraperitoneally (i.p.) with 0.9% NaCl solution containing
2 mg D-glucose / 1 g body weight. Blood samples for glucose
measurements were taken at 0, 5, 10, 15, 30, 60 and 120 minutes
after the glucose load.
Islet isolation and in vitro insulin secretion assay
Mice were sacrificed by cervical dislocation and pancreatic islets
were isolated by collagenase P digestion (Boehringer Mannheim,
Bromma, Sweden). Insulin release in vitro was measured in static
incubations [39]. Briefly, freshly isolated islets were preincubated
for 30 minutes at 37uC in a Krebs-Ringer bicarbonate buffer
supplemented with 1 mM glucose (pH 7.4). The medium was
gassed with 95% O2 and 5% CO2 to obtain constant pH and
oxygenation. Groups of 5 islets were then incubated in 0.2 ml
Krebs-Ringer buffered solution supplemented with either 1 mM
or 20 mM glucose for 60 minutes at 37uC. Immediately after
incubation, an 80 ml aliquot of the medium was removed and the
amount of secreted insulin was determined by ELISA (Rat Insulin
ELISA-Kit, Mercodia, NC, USA). Insulin content was determined
by RIA (radio immuno assay) after sonication and treatment with
acid ethanol as previously described [39].
Transmission Electron Microscopy
Pancreatic islets were harvested from 2 week and 11 week old b-
cell-specific RIP-Cre Dicer1D/D mice and their control littermates
and fixated in 2.5% glutaraldehyde for 1 h at 4u C. Thereafter
they were treated with 1% osmium tetroxide, dehydrated and
embedded in Durcupan (Sigma, Sweden) before being cut into 70–
90 nm ultrathin sections. The sections were put on Cu-grids and
contrasted with uranyl acetate and lead citrate before examined in
a JEM 1230 electron microscope (JEOL-USA. Inc., MA, USA).
Micrographs were analysed with respect to the intracellular
granular distribution using similar methods that have been
described elsewhere [40]. The apparent diameter of individual
LDCVs was determined with the image processing software Scion
Image (NIH freeware). The LDCV volume density, the docked
LDCV surface density and LDCV profiles were calculated using
in-house software programmed in MatLab (Matlab7).
Histological and immunohistochemical analysis
After removal of the pancreata, one half of each pancreas was
fixed with 4% formaldehyde and the other half rapidly frozen in
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Tissue-TekH O.C.T.TM Compound (Sakura Finetek, Europe) on dry
ice overnight, then stored at 280uC. Fixed tissues were processed
for paraffin embedding. Serial 5 mm thick sections were prepared
and stained. Paraffin-embedded sections were stained with
hematoxylin/eosin (Sigma) to assess pancreatic islets histology
and morphology in the experimental animals.
The immunofluorescence stainings were performed on paraffin
sections or cryo sections. Paraffin sections were incubated with the
following primary antibodies: guinea pig anti-insulin (1:1000),
guinea pig anti-glucagon (1:600), rabbit anti-glucagon (1:1000) (all
from Eurodiagnostica, Malmo¨, Sweden) and rabbit anti-Ki67
(1:200) (Novocastra Laboratories Ltd, Newcastle Upon Tyne,
UK). Cryosections were fixed in acetone for 7 min, blocked with
BSA and incubated with primary antibodies (or mixtures, if
double-stained) at 4uC overnight, washed three times for 5 min in
PBS, then incubated with FITC-conjugated anti guinea pig IgG
(1:200) and Cy3-conjugated anti-rabbit IgG (1:300) (both from
Jackson Immunoresearch Laboratories Inc, West Grove, PA)
secondary antibodies for 45 minutes at room temperature. Cell
nuclei were visualized after mounting with ProLong Gold antifade
reagent with DAPI (Invitrogen, Carlsbad, CA, USA). Immuno-
stainings were visualized using a Zeiss LSM510 Confocal
microscope and laser excitations wavelengths of 488 nm and
543 nm. To control the specificities of the immunostaining
procedures, the primary antibodies were replaced by normal
serum from the appropriate species or by PBS. Quantification of
insulin- and glucagon positive cells was measured using Zeiss LSM
510 program and was expressed as the ratio between insulin – and
glucagon fluorescence in each islet.
Optical Projection Tomography (OPT)
The OPT technology was used to visualize the total ß-cells in the
experimental pancreas. In brief, pancreas from RIP-Cre Dicer1D/D
and control mice were dissected, cleaned of residual fat tissue and
immediately submersed into freshly made 4% paraformaldehyde
(Sigma P6148) in PBS for 3 h at 4uC, washed in PBS stepwise
transferred to 100% methanol (MeOH) and stored at 220uC.
Subsequently the pancreatic samples were stained with primary
antibody Guinea Pig anti-Insulin (A0564, Dako) and secondary
antibody goat anti GP Alexa Fluor 594 (A-11076, Invitrogen). OPT
scannings of the pancreatic samples were carried out using the
Bioptonics 3001 OPT M scanner (Bioptonics), with exciter D560/
406 and emitter E610lpv2 filter (Chroma) as described previously
[26]. Tomographic re-constructions were generated by using the
NRecon V1.6.1.0 (Skyscan, Belgium) software and reconstructed
images were further assessed using Bioptonics viewer V2.0
(Bioptonics) as previously described [26]. Further quantification
for islet number was done using ImageJ 1.45n software. Briefly,
image stack was opened using import/image sequence and saved as
.avi file. After setting the scale globally the image channels were
splitted and only the channel having the insulin staining was further
used for quantitative analysis. This was first converted to 8 bit and
then threshold was set to cover all the islets throughout the stack. 3D
object counter plugin was used to count the number of islets.
Possible artifacts were ruled out manually by using the synchronize
tool and going through each slide to get the correct number of
particles. The quantification of the beta cell volume was done by
Volocity v5.2.1 (PerkinElmer) as per published method [26,27].
Possible artifacts were omitted manually by going through slides to
generate the correct beta cell volumes.
b-cell sorting
b-cell sorting was performed based on Newport Green-Ac
staining as described by B. Lukowiak et al. with some
modifications [41]. Briefly, islets from control littermates and
RIP-Cre Dicer1D/D mice were incubated in a calcium-free buffer in
37uC for 12 minutes and then dissociated into single cell
suspension by repeated pipetting. Islet cells were then incubated
for 90 minutes in Opti-MEM minimal medium (Gibco, Invitro-
gen, Carlsbad, CA, USA) supplemented with 2.8 mM D-glucose
and 1% L-glutamin. Subsequently, the cells were incubated with
1 mM Newport Green Ac-ester (Invitrogen, Carlsbad, CA, USA)
and 1 ml/ml Pluronic F-127 dispersing agent (Invitrogen, Carls-
bad, CA, USA) in 37uC for 30 minutes, to facilitate Ac-ester cell
loading. Finally, cells were washed in indicator-free Opti-MEM
medium and incubated for a further 30 minutes in 37uC to allow
complete de-esterification of intra-cellular AM-esters. Newport
Green-Ac stained islets cells were then subjected to cell sorting
using a standard equipped fluorescence activated cell sorting
(FACS) instrument (FACSaria, BD Biosciences, San Diego, CA,
USA). Dead-cell discrimination was performed by staining cells
with 7AAD (BD Pharmingen, USA). Cells were kept on ice during
sorting procedures. Excitation was performed with the blue laser at
488 nm, and the high Newport Green positive cells were sorted in
the Fl.1 channel. A fraction of sorted cells was placed on glass
slides to confirm purity by immunofluorescence microscopy and
viability while the rest of the cells were used for RNA purification
as described below. Cell sorting analysis was performed using the
Diva 6.1 software (BD Biosciences, San Diego, CA, USA).
Immunofluorescence microscopy of sorted b-cells
Sorted b-cells were cultured for 48 hours on cover glasses in
RPMI 1640 (Gibco, Invitrogen) with Peni-Strep, 10% FCS and
1% L-glutamin to attach on the glass for later immunohistochem-
istry staining. Cell fractions were carefully washed with PBS after
culture, and fixed with 4% paraformaldehyde for 20 minutes at
room temperature. The cells were then permeabilized and blocked
with PBS containing 0.1% Triton X-100 and 10% BSA for
45 minutes at room temperature. After blocking, the cells were
incubated with 10 mg/ml monoclonal rat anti-mouse insulin IgG
antibody (R&D Systems) in 4uC over night, followed by goat anti-
rat IgG-Phycoerythrin secondary antibody / or goat anti-rat
Alexa-456. Mounting was performed with ProLong Gold antifade
reagent with DAPI (Invitrogen, Carlsbad, CA, USA).
Flow cytometry analysis of islet cells
Mouse islets were dissociated into cell suspension and fixed with
Fixation/Permeabilization Buffer for 1.5 h, 4uC. After washing
twice with Permeabilization/Wash Buffer (eBiosciences, San
Diego, CA, USA), islet cells were stained with monoclonal rat-
anti mouse insulin-phycoerythrin (PE) and/or monoclonal rat-anti
mouse glucagon-allophycocyanin (APC) antibody (both from R&D
Systems, MN, USA). Antibodies were direct-conjugated with
Lightning Link-PE or APC (InnovaBiosciences, Cambridge, UK)
for flow cytometry purposes before use. Islet cells were incubated
in the dark with antibodies for 30 minutes at 4uC and then washed
twice again with Permeabilization/Wash Buffer before resuspend
them in staining buffer and acquired by flow cytometry on
FACSCalibur Instrument and data were analyzed using CellQuest
software (both from Becton Dickinson, San Jose, CA, USA).
Quantitative PCR (qPCR)
Total RNA from whole brain and FACS-sorted control and
RIP-Cre Dicer1D/D-b-cells was extracted using the Qiagen
miRNeasy isolation kit according to manufacturer’s protocol
(Qiagen, Hilden, Germany). The obtained RNA was quantified by
NanoDrop ND-1000 (Thermo Fisher Scientific, USA) and
subjected to reverse transcription using Quantitect Reverse
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Transcription Kit (Qiagen, Hilden, Germany), according to the
manufacturer’s suggested reaction conditions. qPCR was per-
formed in triplicates using Taqman assays (Applied Biosystems,
Foster City, CA, USA) for mouse insulin, mouse Dicer exon
boundary 20–21, and mouse pri-miR-375. Mouse Hprt1 and
cyclophilin were used as endogenous controls. For mature miR-
375, stem-loop qPCR was performed normalized against
snoRNA-202 and snoRNA-412. All runs were performed on
ABI 7900 HT Fast Real-Time PCR Detection System (Applied
Biosystems, Foster City, CA, USA).
Global microRNA expression profiling
Total RNA from sorted b-cells of wildtype, Dicer1flox/flox and RIP-
Cre Dicer1D/D mice was extracted using the Qiagen miRNeasy
isolation kit (Qiagen, Hilden, Germany). 50 ng of total RNA from
each sample were labeled with the miRCURYTM Hy3TM dye using
the accompanying kit and hybridized on the miRCURYTM LNA
Array (v.11.0) according to manufacturer’s protocol for Maui
hybridisation chamber (Exiqon, Vedbaek, Denmark). Images were
acquired using the AxonH GenePix 4000B scanner and GenePix
software. After background subtraction from foreground signals,
intensities within arrays were normalized using the loess normal-
ization algorithm while quantile normalization was used between
arrays as implemented in the web-fronted R-based array analysis
tool, CARMAWeb 1.4. [42]. Only signals.50 were considered for
analysis. The log2 values were used to generate heatmap using
TreeView (http://jtreeview.sourceforge.net).
In situ Apoptosis detection
To identify apoptotic cells within the pancreatic islets, the
Terminal Deoxynucleotidyl Transferase (TdT)-mediated dUTP
end labelling (TUNEL) assay was used in paraffin embedded
sections. The assay was performed accordingly to the manufac-
turer recommendation (TACS TdT-Fluorescein In Situ Apoptosis
Detection Kit, R&D System Europe, Ltd, Abingdon, UK).’’
Nuclease-treated pancreas section from littermate control mice
was used as positive control for TUNEL staining.
Statistical analysis
Differences in the incidence of diabetes were assessed using
Kaplan–Meier analysis. Statistical significances of differences
between means were estimated by Student’s t-test. Values of
P,0.05 were considered significant.
Supporting Information
Figure S1 b-cell specific knock-out of Dicer1 does not
affect Dicer1 expression in brain or feeding behaviour.
A. Dicer1 expression in brain from RIP-Cre Dicer1D/D mice and
control littermates (control). Expression is normalized to HPRT and
cyclophilin expression levels. B. Weight of 6 week-old RIP-Cre
Dicer1D/D mice and control littermates (Control) measured during 6
days. C. Food consumption during a 5 days period in 6 week old
RIP-Cre Dicer1D/D mice and control littermates (Control).
(PDF)
Figure S2 Electron micrograph of b-cells from 2 week
old control (top) and RIP-Cre Dicer1D/D (bottom) mice.
In the left images (low magnification), the plasma membrane
surrounding the analyzed b-cell is marked by a black line. The
area within the dotted rectangle is high-lighted in images (higher
magnification) to the right. Docked granules are marked with black
arrows in the images to the right. Scale bars 2 mm (left images) and
0.5 mm (right images). b: b-cell; a: a-cell; N: nucleus; g: granule;
m:mitochondria.
(PDF)
Figure S3 Global miRNA profiling in sorted b-cells.
Pancreatic islets were isolated from 7 RIP-Cre Dicer1D/D and 7
littermate control mice. b-cells were sorted using flow cytometry to
.98% purity. Total RNA was extracted and used for PCR and
array hybridization. This image shows the results from the array.
A combined 60 miRNAs exhibited detectable signals from the
arrays. 26 were not detected in the knockout including the most
abundant islet miRNAs, miR-375 and miR-7a. (black to yellow:
normalized array signal; grey: no signal).
(PDF)
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